Tinea unguium
ICD-10 B46.1 is a billable code used to indicate a diagnosis of tinea unguium.
Tinea unguium, also known as onychomycosis, is a fungal infection that affects the nails, particularly the toenails. It is characterized by the thickening, discoloration, and potential separation of the nail from the nail bed. The condition is primarily caused by dermatophytes, but can also be due to non-dermatophyte molds and yeasts. Risk factors include advanced age, diabetes mellitus, immunocompromised states, and poor circulation. Symptoms may include nail brittleness, crumbling, and a foul odor. Diagnosis is typically made through clinical examination and confirmed by laboratory tests such as nail clippings or scrapings sent for fungal culture or microscopy. Treatment options include topical antifungals like ciclopirox and systemic antifungals such as terbinafine and itraconazole. In immunocompromised patients, the infection may be more severe and resistant to treatment, necessitating a more aggressive therapeutic approach. Regular follow-up is essential to monitor treatment efficacy and prevent recurrence.
Detailed clinical notes on nail examination, treatment plans, and follow-up assessments.
Patients presenting with nail discoloration, thickening, or pain.
Ensure accurate documentation of the type of fungus and any underlying conditions.
Comprehensive history of immunocompromised status, treatment response, and any secondary infections.
Immunocompromised patients with recurrent or severe fungal infections.
Document the patient's immune status and any complications arising from the infection.
Used when extensive nail debridement is necessary due to fungal infection.
Document the extent of debridement and the reason for the procedure.
Dermatologists should ensure proper coding for debridement procedures.
Tinea unguium is primarily caused by dermatophyte fungi, but can also be due to non-dermatophyte molds and yeasts.
Diagnosis is made through clinical examination and confirmed by laboratory tests such as nail clippings or scrapings sent for fungal culture or microscopy.
Treatment options include topical antifungals like ciclopirox and systemic antifungals such as terbinafine and itraconazole.
